Project Grant F32AI191478
Award Date 2/15/26
Completion Date 8/31/28
Dollars Obligated $80K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
- This federal Project Grant award of $489,500 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), is focused on exploring the utility of antimicrobial blue light (ABL) for treating otitis media (OM), the most common pediatric infection. The key objectives of this 24-month project are to: 1) investigate the in vitro efficacy of ABL in killing primary otopathogens, including...
- This $496,496 Project Grant was awarded on August 1, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports the development of chemical probes to enable imaging and phototherapy treatment of otitis media (OM), or middle ear infection, a common childhood condition. The probes will target bacterial enzymes involved in cell wall...
- The National Institute on Deafness and Other Communication Disorders (NIDCD), through its Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded a $306,872 project grant to Mstatt LLC (doing business as North Coast Photonics) to develop a safe, low-power digital laser otoscope for improved identification and diagnosis of otitis media with effusion (OME) in young children. OME is a common cause of childhood hearing loss, but primary care physicians often...
- Pionear Technologies Inc. received a $699,002 Project Grant award from the National Institute on Deafness and Other Communication Disorders within the Department of Health and Human Services. The award is part of the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) to develop novel liquid-infused tympanostomy tubes with optimized lumen geometry and slippery material design. The goal of the project is to engineer tympanostomy tubes that more efficiently...
- This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to use whole genome sequencing (WGS) and diagnostic allele (DA) surveillance to study bacterial infection transmission and persistence dynamics within neonatal intensive care units (NICUs). The $881,303 award will fund research to: Determine patient, pathogen, and environment-specific factors contributing to infection...
- The National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded a $306,311 project grant to AO Technologies, LLC to develop a high-performance, reduced-cost optical coherence tomography (OCT) otoscope. This handheld device aims to provide improved three-dimensional imaging of the tympanic membrane and middle ear, which could lead to better diagnosis and treatment of hearing and...
- This $451,000 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) aims to identify new molecular targets for antimicrobial agents against the gram-negative bacterial pathogens Burkholderia pseudomallei and Pseudomonas aeruginosa. The research approach utilizes chemical synthetic lethality, whereby subinhibitory doses of antibiotics are used to expose vulnerabilities...
- This Project Grant award of $254,478 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research to determine the mechanism of resistance for lead peptide-phosphorodiamidate morpholino oligomer (PPMO) compounds against the bacterial pathogens Klebsiella pneumoniae, Acinetobacter baumannii, and Burkholderia cepacia complex. PPMOs are a new class of antibacterial compounds that have shown promise in killing a variety of...
- This $384,863 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program supports research to develop a novel radiotracer imaging agent for detecting Gram-positive bacterial infections associated with implanted medical devices. The key products and services to be delivered include: In vitro testing of a bivalent radiotracer agent...
- This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal grant program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), provides $445,861 to develop a novel low-cost imaging device based on optical coherence tomography (OCT) technology. The device enables real-time, 3D visualization of the tympanic membrane and middle ear structures, including the ossicles and cochlear promontory. This...